Iðunn Venture Fund
Overview
Iðunn Venture Fund is a venture capital fund based in Reykjavík, Iceland, focusing on life sciences and health technology investments. The fund was established in March 2021 with an initial size of 7.3 billion ISK. Its investment period spans five years, concentrating on companies with robust business development plans and management capabilities to drive growth and prepare for scaling. The fund has invested in several companies, including Coripharma, EpiEndo Pharmaceuticals, Kara Connect, NeckCare, and PLAIO. Notably, in 2024, Iðunn led a €4.3 million investment in PLAIO, an AI-driven pharmaceutical platform. In 2022, the fund invested in EpiEndo Pharmaceuticals, a company developing a novel drug for chronic obstructive pulmonary disease (COPD), marking the first Icelandic drug candidate to enter clinical trials. Iðunn's investment philosophy emphasizes long-term growth in the life sciences and health technology sectors, aiming to support innovative companies that can make a significant impact in their respective fields. The fund's strategic approach includes active involvement in portfolio companies to foster development and prepare them for subsequent stages of growth and scaling.
Investment Focus
- Companies in life sciences and health technology sectors with strong business development plans and management capabilities
Portfolio Companies
Reach Iðunn Venture Fund directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Iðunn Venture Fund
What sectors does Iðunn Venture Fund invest in?
Iðunn Venture Fund invests in Digital Health, Biotech and Medtech, and is based in Reykjavík, Iceland. Iðunn Venture Fund is listed as a venture capital in the ConnectSafely investor database.
What stage does Iðunn Venture Fund invest at?
Iðunn Venture Fund backs companies at Seed, Early Stage and Growth.
Which regions does Iðunn Venture Fund invest in?
Iðunn Venture Fund invests across Iceland.
What companies has Iðunn Venture Fund invested in?
Iðunn Venture Fund's portfolio includes Plaio, EpiEndo Pharmaceuticals, Coripharma, Kara Connect and NeckCare.
Last updated · Source: ConnectSafely investor database
